Medidata Alternatives

Compare Medidata alternatives for EDC and clinical trial software: lighter, faster options with eConsent, ePRO, and 21 CFR Part 11–aligned controls.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

Medidata Alternatives

Teams evaluating Medidata often look for alternatives that offer faster implementation, simpler pricing, and integrated eConsent and ePRO without enterprise-scale complexity. This page is for sponsors and CROs actively comparing EDC vendors or looking for a lighter, faster option for early-phase and mid-size trials. Capture is one alternative: a single platform for EDC, eConsent, ePRO, and safety with 21 CFR Part 11–aligned controls and HIPAA-aligned security, built for speed and flexibility without enterprise overhead.

Why teams look for Medidata alternatives

Medidata is widely used for large, global Phase 3 trials. Many early-phase and small-to-mid-size teams find that implementation timelines, pricing models, and feature scope are geared toward enterprise programs. If you need rapid go-live, integrated eConsent and ePRO, and 21 CFR Part 11–aligned controls without long implementation or per-seat complexity, evaluating alternatives is common. Transparent comparison criteria include implementation speed, pricing fit, eConsent/ePRO integration, and support for sponsor validation.

What to look for when comparing EDC alternatives

  • Implementation speed and time to first patient
  • Pricing model: per-seat vs. study-based; fit for early-phase and small trials
  • Integrated eConsent, ePRO, and EDC in one platform and one audit trail
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation and support for sponsor validation and UAT
  • Export for analysis and regulatory submissions

Why teams consider switching from Medidata

  • Long implementation cycles and change control for early-phase studies
  • Pricing and contracts geared toward large, global trials
  • Separate or complex setup for eConsent and ePRO
  • Need for a lighter, faster option for Phase 1–2 and small biotech

Where Capture fits as an alternative

  • Single platform for EDC, eConsent, ePRO, and safety; one audit trail
  • Rapid study build and deployment; no enterprise implementation overhead
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation to support sponsor validation (Enterprise); pricing that scales with study size
  • Built for early-phase and mid-size trials; compare options or book a demo to evaluate fit

Related

Clinical trial software for small biotechEDC for Phase 1 trialsCompare REDCap

FAQ

Questions we hear a lot

Who is this Medidata alternatives page for?
Sponsors and CROs actively comparing EDC vendors or looking for a lighter, faster option for early-phase and mid-size trials. If you need rapid go-live and integrated eConsent/ePRO without enterprise complexity, evaluating alternatives is common.
What should I compare when evaluating EDC alternatives?
Consider implementation speed, pricing fit for your study size, whether eConsent and ePRO are integrated, 21 CFR Part 11–aligned controls, and support for sponsor validation. Capture offers one platform with these attributes for early-phase and mid-size trials.
Is Capture 21 CFR Part 11–aligned?
Yes. Capture is designed with 21 CFR Part 11–aligned controls (electronic signatures, audit trails, access control) and HIPAA-aligned security. We provide documentation to support sponsor validation when required (Enterprise).

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.